ID
stringlengths 11
11
| tags
stringlengths 10
777
| text
stringlengths 2
1.5k
| dataset_num
int64 1
3
| tokens
sequence | ner_tags
sequence |
|---|---|---|---|---|---|
NCT01850355 | 19:35:chronic_disease,19:26:chronic_disease,37:40:treatment, | History of active seizure disorder (EEG suggestive of seizure activity and/or history of seizure in last 1 month) | 3 | [
"History",
"of",
"active",
"seizure",
"disorder",
"(",
"EEG",
"suggestive",
"of",
"seizure",
"activity",
"and/or",
"history",
"of",
"seizure",
"in",
"last",
"1",
"month",
")"
] | [
0,
0,
0,
2,
2,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01849146 | 66:89:treatment,91:103:treatment,105:118:treatment,122:349:treatment,354:370:treatment,381:392:cancer | going on Arm 1 or combination dose cohort must not have received prior radiation therapy, chemotherapy, immunotherapy or therapy with biologic agent (including immunotoxins, immunoconjugates, antisense, peptide receptor antagonists, interferons, interleukins, tumor infiltrating lymphocytes [TIL], lymphokine-activated killer [LAK] or gene therapy), or hormonal therapy for their brain tumor | 3 | [
"going",
"on",
"Arm",
"1",
"or",
"combination",
"dose",
"cohort",
"must",
"not",
"have",
"received",
"prior",
"radiation",
"therapy",
",",
"chemotherapy",
",",
"immunotherapy",
"or",
"therapy",
"with",
"biologic",
"agent",
"(",
"including",
"immunotoxins",
",",
"immunoconjugates",
",",
"antisense",
",",
"peptide",
"receptor",
"antagonists",
",",
"interferons",
",",
"interleukins",
",",
"tumor",
"infiltrating",
"lymphocytes",
"[",
"TIL",
"]",
",",
"lymphokine-activated",
"killer",
"[",
"LAK",
"]",
"or",
"gene",
"therapy",
")",
",",
"or",
"hormonal",
"therapy",
"for",
"their",
"brain",
"tumor"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
3,
3
] |
NCT01849146 | 15:30:treatment,32:40:treatment,80:87:treatment,89:93:treatment | may not be on anti-coagulants (warfarin, etc.) other than low-molecular weight heparin (LMWH) | 3 | [
"may",
"not",
"be",
"on",
"anti-coagulants",
"(",
"warfarin",
",",
"etc",
".",
")",
"other",
"than",
"low-molecular",
"weight",
"heparin",
"(",
"LMWH",
")"
] | [
0,
0,
0,
0,
1,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
1,
0
] |
NCT01849146 | 14:34:chronic_disease,77:93:chronic_disease,107:131:chronic_disease,133:157:chronic_disease,159:177:chronic_disease,182:201:chronic_disease | uncontrolled intercurrent illness including, but not limited to, ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study requirements, are ineligible | 3 | [
"uncontrolled",
"intercurrent",
"illness",
"including",
",",
"but",
"not",
"limited",
"to",
",",
"ongoing",
"or",
"active",
"infection",
",",
"symptomatic",
"congestive",
"heart",
"failure",
",",
"unstable",
"angina",
"pectoris",
",",
"cardiac",
"arrhythmia",
",",
"or",
"psychiatric",
"illness/social",
"situations",
"that",
"would",
"limit",
"compliance",
"with",
"study",
"requirements",
",",
"are",
"ineligible"
] | [
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
2,
2,
2,
0,
2,
2,
2,
0,
2,
2,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01842399 | 100:115:chronic_disease,128:142:treatment,173:194:chronic_disease,,223:229:chronic_disease,237:246:treatment | Unable to perform treadmill testing due to reasons such as orthopedic problems, moderate to severe aortic stenosis as found on echocardiogram at ScreeningVisit, history of myocardial infarction in the last three months or angina (under treatment) | 3 | [
"Unable",
"to",
"perform",
"treadmill",
"testing",
"due",
"to",
"reasons",
"such",
"as",
"orthopedic",
"problems",
",",
"moderate",
"to",
"severe",
"aortic",
"stenosis",
"as",
"found",
"on",
"echocardiogram",
"at",
"ScreeningVisit",
",",
"history",
"of",
"myocardial",
"infarction",
"in",
"the",
"last",
"three",
"months",
"or",
"angina",
"(",
"under",
"treatment",
")"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
1,
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
2,
0,
0,
1,
0
] |
NCT01835626 | 1:4:cancer,,62:81:treatment,97:115:treatment | BCC that has recurred in the same location after two or more surgical procedures and successful curative resection is deemed unlikely | 3 | [
"BCC",
"that",
"has",
"recurred",
"in",
"the",
"same",
"location",
"after",
"two",
"or",
"more",
"surgical",
"procedures",
"and",
"successful",
"curative",
"resection",
"is",
"deemed",
"unlikely"
] | [
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
1,
1,
0,
0,
0
] |
NCT01835626 | 27:48:chronic_disease,196:216:treatment,322:331:treatment | History of other disease, metabolic dysfunction, physical examination finding, or clinical laboratory finding giving reasonable suspicion of a disease or condition that contraindicates use of an investigational drug or that might affect interpretation of the results of the study or renders the patient at high risk form treatment complications | 3 | [
"History",
"of",
"other",
"disease",
",",
"metabolic",
"dysfunction",
",",
"physical",
"examination",
"finding",
",",
"or",
"clinical",
"laboratory",
"finding",
"giving",
"reasonable",
"suspicion",
"of",
"a",
"disease",
"or",
"condition",
"that",
"contraindicates",
"use",
"of",
"an",
"investigational",
"drug",
"or",
"that",
"might",
"affect",
"interpretation",
"of",
"the",
"results",
"of",
"the",
"study",
"or",
"renders",
"the",
"patient",
"at",
"high",
"risk",
"form",
"treatment",
"complications"
] | [
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0
] |
NCT01835626 | 7:19:treatment,47:53:cancer,86:95:treatment,86:103:treatment | Prior radiotherapy to the region of the study cancer that would result in overlap of radiation therapy fields in such a way that curative intent with radiation cannot be met | 3 | [
"Prior",
"radiotherapy",
"to",
"the",
"region",
"of",
"the",
"study",
"cancer",
"that",
"would",
"result",
"in",
"overlap",
"of",
"radiation",
"therapy",
"fields",
"in",
"such",
"a",
"way",
"that",
"curative",
"intent",
"with",
"radiation",
"can",
"not",
"be",
"met"
] | [
0,
1,
0,
0,
0,
0,
0,
0,
3,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01829958 | 24:44:treatment,61:78:treatment,91:113:treatment,122:134:treatment,138:168:treatment,177:186:treatment,190:200:treatment | Must be starting a new chemotherapy regimen (patients whose treatment regimen includes an immunomodulatory agent such as lenalidomide or small molecule targeted agents such as Ibrutinib or Idelelasib | 3 | [
"Must",
"be",
"starting",
"a",
"new",
"chemotherapy",
"regimen",
"(",
"patients",
"whose",
"treatment",
"regimen",
"includes",
"an",
"immunomodulatory",
"agent",
"such",
"as",
"lenalidomide",
"or",
"small",
"molecule",
"targeted",
"agents",
"such",
"as",
"Ibrutinib",
"or",
"Idelelasib"
] | [
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
1,
1,
0,
0,
1,
1,
0,
0,
1,
0,
1,
1,
1,
1,
0,
0,
1,
0,
1
] |
NCT01827384 | 5:18:treatment,20:32:treatment,37:50:treatment,,,102:114:treatment,118:129:treatment | Any prior therapy, radiotherapy, or major surgery must have been completed >= 3 weeks (> 6 weeks for nitrosoureas or mitomycin C) or 5 half-lives of the agent (whichever is shorter) prior to enrollment on protocol | 3 | [
"Any",
"prior",
"therapy",
",",
"radiotherapy",
",",
"or",
"major",
"surgery",
"must",
"have",
"been",
"completed",
">",
"=",
"3",
"weeks",
"(",
">",
"6",
"weeks",
"for",
"nitrosoureas",
"or",
"mitomycin",
"C",
")",
"or",
"5",
"half-lives",
"of",
"the",
"agent",
"(",
"whichever",
"is",
"shorter",
")",
"prior",
"to",
"enrollment",
"on",
"protocol"
] | [
0,
1,
1,
0,
1,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01827384 | 15:30:cancer,34:47:chronic_disease,51:87:treatment,78:87:treatment,89:98:treatment | Patients with bone metastases or hypercalcemia on intravenous bisphosphonate treatment, denosumab, or similar agents are eligible to participate and may continue this treatment | 3 | [
"Patients",
"with",
"bone",
"metastases",
"or",
"hypercalcemia",
"on",
"intravenous",
"bisphosphonate",
"treatment",
",",
"denosumab",
",",
"or",
"similar",
"agents",
"are",
"eligible",
"to",
"participate",
"and",
"may",
"continue",
"this",
"treatment"
] | [
0,
0,
3,
3,
0,
2,
0,
1,
1,
1,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01827384 | 26:65:cancer,84:93:treatment,122:130:chronic_disease,163:184:treatment, | Patients with history of central nervous system (CNS) metastases who have received treatment and who either have not had seizures or have been on stable doses of anti-seizure medicine and had no seizures for 4 weeks | 3 | [
"Patients",
"with",
"history",
"of",
"central",
"nervous",
"system",
"(",
"CNS",
")",
"metastases",
"who",
"have",
"received",
"treatment",
"and",
"who",
"either",
"have",
"not",
"had",
"seizures",
"or",
"have",
"been",
"on",
"stable",
"doses",
"of",
"anti-seizure",
"medicine",
"and",
"had",
"no",
"seizures",
"for",
"4",
"weeks"
] | [
0,
0,
0,
0,
3,
3,
3,
3,
3,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0
] |
NCT01827384 | 79:116:chronic_disease,182:206:chronic_disease,208:223:chronic_disease,234:252:chronic_disease,254:275:chronic_disease,,298:324:chronic_disease,358:387:chronic_disease,389:402:chronic_disease,422:449:chronic_disease,466:483:chronic_disease,504:527:chronic_disease,504:515:chronic_disease,598:621:chronic_disease | Patients with uncontrolled intercurrent illness including, but not limited to psychiatric illness/social situations that would limit compliance with study requirements, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, myocardial infarction in the past 6 months, invasive fungal infections, or active (acute or chronic) or uncontrolled severe infection, liver disease such as cirrhosis, decompensated liver disease, and active and chronic hepatitis (i.e., quantifiable hepatitis B virus [HBV]-DNA and/or positive hepatitis B surface antigen [HbsAg], quantifiable hepatitis C virus [HCV]-ribonucleic acid [RNA]) | 3 | [
"Patients",
"with",
"uncontrolled",
"intercurrent",
"illness",
"including",
",",
"but",
"not",
"limited",
"to",
"psychiatric",
"illness/social",
"situations",
"that",
"would",
"limit",
"compliance",
"with",
"study",
"requirements",
",",
"symptomatic",
"congestive",
"heart",
"failure",
",",
"unstable",
"angina",
"pectoris",
",",
"cardiac",
"arrhythmia",
",",
"myocardial",
"infarction",
"in",
"the",
"past",
"6",
"months",
",",
"invasive",
"fungal",
"infections",
",",
"or",
"active",
"(",
"acute",
"or",
"chronic",
")",
"or",
"uncontrolled",
"severe",
"infection",
",",
"liver",
"disease",
"such",
"as",
"cirrhosis",
",",
"decompensated",
"liver",
"disease",
",",
"and",
"active",
"and",
"chronic",
"hepatitis",
"(",
"i.e.",
",",
"quantifiable",
"hepatitis",
"B",
"virus",
"[",
"HBV",
"]",
"-DNA",
"and/or",
"positive",
"hepatitis",
"B",
"surface",
"antigen",
"[",
"HbsAg",
"]",
",",
"quantifiable",
"hepatitis",
"C",
"virus",
"[",
"HCV",
"]",
"-ribonucleic",
"acid",
"[",
"RNA",
"]",
")"
] | [
0,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
2,
0,
2,
2,
0,
0,
2,
2,
0,
2,
2,
0,
0,
0,
0,
0,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
2,
2,
2,
0,
0,
0,
0,
0,
2,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01824836 | 33:49:treatment,55:65:treatment,67:76:treatment,81:92:treatment,96:112:treatment,134:147:cancer | Patients must not have received prior AI therapy with exemestane, letrozole, or anastrozole as adjuvant therapy or for prevention of breast cancer | 3 | [
"Patients",
"must",
"not",
"have",
"received",
"prior",
"AI",
"therapy",
"with",
"exemestane",
",",
"letrozole",
",",
"or",
"anastrozole",
"as",
"adjuvant",
"therapy",
"or",
"for",
"prevention",
"of",
"breast",
"cancer"
] | [
0,
0,
0,
0,
0,
1,
1,
1,
0,
1,
0,
1,
0,
0,
1,
0,
1,
1,
0,
0,
0,
0,
3,
3
] |
NCT01822522 | 1:12:treatment,14:26:treatment,28:40:treatment,42:54:treatment,56:67:treatment,69:81:treatment | Antifungals: itraconazole, ketoconazole, voriconazole, fluconazole, posaconazole | 3 | [
"Antifungals",
":",
"itraconazole",
",",
"ketoconazole",
",",
"voriconazole",
",",
"fluconazole",
",",
"posaconazole"
] | [
1,
0,
1,
0,
1,
0,
1,
0,
1,
0,
1
] |
NCT01822522 | 30:45:treatment,53:84:treatment,90:106:treatment,,,284:299:treatment | The participant has received prior treatment with a small molecule kinase inhibitor or a hormonal therapy (including investigational kinase inhibitors or hormones) within 4 weeks or five half-lives of the compound or active metabolites, whichever is longer, before the first dose of study treatment | 3 | [
"The",
"participant",
"has",
"received",
"prior",
"treatment",
"with",
"a",
"small",
"molecule",
"kinase",
"inhibitor",
"or",
"a",
"hormonal",
"therapy",
"(",
"including",
"investigational",
"kinase",
"inhibitors",
"or",
"hormones",
")",
"within",
"4",
"weeks",
"or",
"five",
"half-lives",
"of",
"the",
"compound",
"or",
"active",
"metabolites",
",",
"whichever",
"is",
"longer",
",",
"before",
"the",
"first",
"dose",
"of",
"study",
"treatment"
] | [
0,
0,
0,
0,
1,
1,
0,
0,
1,
1,
1,
1,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT01822522 | 45:70:treatment,155:162:treatment,,,396:405:treatment | participants will be eligible regardless of antiretroviral medication (including no antiretroviral medication) provided there is no intention to initiate therapy or the regimen has been stable for at least 4 weeks with no intention to change the regimen within 8 weeks following study entry; as study-specific (antiretroviral-based) strata fill, however, only participants who are receiving the therapies eligible for the remaining open strata will be accrued | 3 | [
"participants",
"will",
"be",
"eligible",
"regardless",
"of",
"antiretroviral",
"medication",
"(",
"including",
"no",
"antiretroviral",
"medication",
")",
"provided",
"there",
"is",
"no",
"intention",
"to",
"initiate",
"therapy",
"or",
"the",
"regimen",
"has",
"been",
"stable",
"for",
"at",
"least",
"4",
"weeks",
"with",
"no",
"intention",
"to",
"change",
"the",
"regimen",
"within",
"8",
"weeks",
"following",
"study",
"entry",
";",
"as",
"study-specific",
"(",
"antiretroviral-based",
")",
"strata",
"fill",
",",
"however",
",",
"only",
"participants",
"who",
"are",
"receiving",
"the",
"therapies",
"eligible",
"for",
"the",
"remaining",
"open",
"strata",
"will",
"be",
"accrued"
] | [
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01821690 | 12:25:chronic_disease,29:38:chronic_disease,42:58:chronic_disease | History of schizophrenia or psychosis or bipolar disorder | 3 | [
"History",
"of",
"schizophrenia",
"or",
"psychosis",
"or",
"bipolar",
"disorder"
] | [
0,
0,
2,
0,
2,
0,
2,
2
] |
NCT01817751 | 24:36:chronic_disease,38:51:chronic_disease,56:79:chronic_disease | History of significant intratumoral, intracerebral, or subarachnoid hemorrhage | 3 | [
"History",
"of",
"significant",
"intratumoral",
",",
"intracerebral",
",",
"or",
"subarachnoid",
"hemorrhage"
] | [
0,
0,
0,
2,
0,
2,
0,
0,
2,
2
] |
NCT01817751 | 47:71:treatment,86:101:treatment,116:133:treatment | persons who require ongoing administration of STRONG CYP3A4 inhibitors and/or STRONG CYP3A4 inducers and/or STRONG CYP2C9 inhibitors | 3 | [
"persons",
"who",
"require",
"ongoing",
"administration",
"of",
"STRONG",
"CYP3A4",
"inhibitors",
"and/or",
"STRONG",
"CYP3A4",
"inducers",
"and/or",
"STRONG",
"CYP2C9",
"inhibitors"
] | [
0,
0,
0,
0,
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT01811498 | 51:73:chronic_disease,164:173:treatment,177:211:treatment | Patients with significant intercurrent medical or psychiatric conditions that would place them at increased risk or affect their ability to receive or comply with treatment or post-treatment clinical monitoring | 3 | [
"Patients",
"with",
"significant",
"intercurrent",
"medical",
"or",
"psychiatric",
"conditions",
"that",
"would",
"place",
"them",
"at",
"increased",
"risk",
"or",
"affect",
"their",
"ability",
"to",
"receive",
"or",
"comply",
"with",
"treatment",
"or",
"post-treatment",
"clinical",
"monitoring"
] | [
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
1,
1,
1
] |
NCT01811368 | 39:41:chronic_disease,43:45:chronic_disease,47:49:chronic_disease,53:72:chronic_disease | Patients who had anything less than a CR (PR, SD or progressive disease) to their last salvage regimen | 3 | [
"Patients",
"who",
"had",
"anything",
"less",
"than",
"a",
"CR",
"(",
"PR",
",",
"SD",
"or",
"progressive",
"disease",
")",
"to",
"their",
"last",
"salvage",
"regimen"
] | [
0,
0,
0,
0,
0,
0,
0,
2,
0,
2,
0,
2,
0,
2,
2,
0,
0,
0,
0,
0,
0
] |
NCT01807117 | 17:19:cancer,25:31:cancer,178:195:cancer,214:227:cancer,249:266:cancer | Either having a T3 (the cancer has grown through the muscularis propria and into the outermost layers of the colon or rectum but not through them) or higher, node positivity or metastatic lesion in the context of rectal cancer or being studied for colorectal cancer follow up, independent of the renal function | 3 | [
"Either",
"having",
"a",
"T3",
"(",
"the",
"cancer",
"has",
"grown",
"through",
"the",
"muscularis",
"propria",
"and",
"into",
"the",
"outermost",
"layers",
"of",
"the",
"colon",
"or",
"rectum",
"but",
"not",
"through",
"them",
")",
"or",
"higher",
",",
"node",
"positivity",
"or",
"metastatic",
"lesion",
"in",
"the",
"context",
"of",
"rectal",
"cancer",
"or",
"being",
"studied",
"for",
"colorectal",
"cancer",
"follow",
"up",
",",
"independent",
"of",
"the",
"renal",
"function"
] | [
0,
0,
0,
3,
0,
0,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
3,
0,
0,
0,
0,
3,
3,
0,
0,
0,
0,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01804634 | 11:22:cancer,17:22:cancer,27:46:cancer,39:46:cancer, | Any other solid tumor and soft tissue sarcoma with an estimated <10% chance of survival will be considered on a case by case basis at the departmental tumor board and/or sarcoma meeting | 3 | [
"Any",
"other",
"solid",
"tumor",
"and",
"soft",
"tissue",
"sarcoma",
"with",
"an",
"estimated",
"<",
"10",
"%",
"chance",
"of",
"survival",
"will",
"be",
"considered",
"on",
"a",
"case",
"by",
"case",
"basis",
"at",
"the",
"departmental",
"tumor",
"board",
"and/or",
"sarcoma",
"meeting"
] | [
0,
0,
3,
3,
0,
3,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01804465 | 27:48:chronic_disease,123:133:treatment,227:235:chronic_disease | Any underlying medical or psychiatric condition, which in the opinion of the investigator will make the administration of ipilimumab hazardous or obscure the interpretation of AEs, such as a condition associated with frequent diarrhea | 3 | [
"Any",
"underlying",
"medical",
"or",
"psychiatric",
"condition",
",",
"which",
"in",
"the",
"opinion",
"of",
"the",
"investigator",
"will",
"make",
"the",
"administration",
"of",
"ipilimumab",
"hazardous",
"or",
"obscure",
"the",
"interpretation",
"of",
"AEs",
",",
"such",
"as",
"a",
"condition",
"associated",
"with",
"frequent",
"diarrhea"
] | [
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2
] |
NCT01804465 | 30:46:treatment,70:96:treatment,98:119:treatment,,206:229:treatment, | Patients receiving any other hormonal therapy, including any dose of megestrol acetate (Megace), Proscar (finasteride), any herbal product known to decrease PSA levels (e.g. Saw Palmetto, PC-SPES), or any systemic corticosteroid, must discontinue the agent for at least four weeks prior to study treatment. Progressive disease as defined above must be documented after discontinuation of any hormonal therapy | 3 | [
"Patients",
"receiving",
"any",
"other",
"hormonal",
"therapy",
",",
"including",
"any",
"dose",
"of",
"megestrol",
"acetate",
"(",
"Megace",
")",
",",
"Proscar",
"(",
"finasteride",
")",
",",
"any",
"herbal",
"product",
"known",
"to",
"decrease",
"PSA",
"levels",
"(",
"e.g",
".",
"Saw",
"Palmetto",
",",
"PC-SPES",
")",
",",
"or",
"any",
"systemic",
"corticosteroid",
",",
"must",
"discontinue",
"the",
"agent",
"for",
"at",
"least",
"four",
"weeks",
"prior",
"to",
"study",
"treatment",
".",
"Progressive",
"disease",
"as",
"defined",
"above",
"must",
"be",
"documented",
"after",
"discontinuation",
"of",
"any",
"hormonal",
"therapy"
] | [
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
1,
1,
1,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01802346 | 1:19:treatment,,90:102:treatment,129:138:treatment | Prior Radiotherapy is allowed, provided at least 2 weeks have elapsed from completion of radiotherapy to initiation of protocol treatment | 3 | [
"Prior",
"Radiotherapy",
"is",
"allowed",
",",
"provided",
"at",
"least",
"2",
"weeks",
"have",
"elapsed",
"from",
"completion",
"of",
"radiotherapy",
"to",
"initiation",
"of",
"protocol",
"treatment"
] | [
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
1
] |
NCT01799538 | 7:24:chronic_disease,32:42:cancer,44:65:chronic_disease,69:84:chronic_disease,86:101:chronic_disease,103:122:chronic_disease,124:139:chronic_disease | Major systemic diseases (i.e., malignancy; myocardial infarction or unstable angina; type 1 diabetes, severe hypertension; liver cirrhosis) | 3 | [
"Major",
"systemic",
"diseases",
"(",
"i.e.",
",",
"malignancy",
";",
"myocardial",
"infarction",
"or",
"unstable",
"angina",
";",
"type",
"1",
"diabetes",
",",
"severe",
"hypertension",
";",
"liver",
"cirrhosis",
")"
] | [
0,
2,
2,
0,
0,
0,
3,
0,
2,
2,
0,
2,
2,
0,
2,
2,
2,
0,
2,
2,
0,
2,
2,
0
] |
NCT01795573 | 1:4:cancer,6:9:cancer,,,,,134:142:cancer, | AML, ALL: Normal values for absolute neutrophil count (>1000/microL) and platelet count (>100,000/microL); Absence of extramedullary leukemia; Less than 5 percent blast cells present in the bone marrow | 3 | [
"AML",
",",
"ALL",
":",
"Normal",
"values",
"for",
"absolute",
"neutrophil",
"count",
"(",
">",
"1000/microL",
")",
"and",
"platelet",
"count",
"(",
">",
"100,000/microL",
")",
";",
"Absence",
"of",
"extramedullary",
"leukemia",
";",
"Less",
"than",
"5",
"percent",
"blast",
"cells",
"present",
"in",
"the",
"bone",
"marrow"
] | [
3,
0,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01795573 | 73:82:treatment,217:249:treatment,267:294:treatment,385:405:treatment | HL: No clinical evidence of disease or disease-related symptoms; A post-treatment residual mass of any size is permitted as long as it is PET negative; Spleen and liver must be non-palpable and without nodules; If a pre-treatment bone marrow biopsy was positive, an adequate bone marrow biopsy from the same site must be cleared of infiltrate; if this is indeterminate by morphology, immunohistochemistry should be negative | 3 | [
"HL",
":",
"No",
"clinical",
"evidence",
"of",
"disease",
"or",
"disease-related",
"symptoms",
";",
"A",
"post-treatment",
"residual",
"mass",
"of",
"any",
"size",
"is",
"permitted",
"as",
"long",
"as",
"it",
"is",
"PET",
"negative",
";",
"Spleen",
"and",
"liver",
"must",
"be",
"non-palpable",
"and",
"without",
"nodules",
";",
"If",
"a",
"pre-treatment",
"bone",
"marrow",
"biopsy",
"was",
"positive",
",",
"an",
"adequate",
"bone",
"marrow",
"biopsy",
"from",
"the",
"same",
"site",
"must",
"be",
"cleared",
"of",
"infiltrate",
";",
"if",
"this",
"is",
"indeterminate",
"by",
"morphology",
",",
"immunohistochemistry",
"should",
"be",
"negative"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
1,
0,
0,
0,
0,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0
] |
NCT01795573 | 1:4:cancer,42:71:treatment,73:95:treatment,100:113:treatment | MDS: May have achieved CR through either hypomethylating agent therapy, induction chemotherapy, or other therapy | 3 | [
"MDS",
":",
"May",
"have",
"achieved",
"CR",
"through",
"either",
"hypomethylating",
"agent",
"therapy",
",",
"induction",
"chemotherapy",
",",
"or",
"other",
"therapy"
] | [
3,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
0,
1,
1,
0,
0,
1,
1
] |
NCT01795313 | 76:97:treatment,,215:236:cancer,250:278:cancer,309:331:treatment | must have previously received standard initial therapy including attempted gross total resection, where safely feasible, and in appropriate circumstances (e.g., those older than one year at initial diagnosis, with non-metastatic tumors and at least microscopic residual disease), involved field fractionated radiation therapy (RT) | 3 | [
"must",
"have",
"previously",
"received",
"standard",
"initial",
"therapy",
"including",
"attempted",
"gross",
"total",
"resection",
",",
"where",
"safely",
"feasible",
",",
"and",
"in",
"appropriate",
"circumstances",
"(",
"e.g.",
",",
"those",
"older",
"than",
"one",
"year",
"at",
"initial",
"diagnosis",
",",
"with",
"non-metastatic",
"tumors",
"and",
"at",
"least",
"microscopic",
"residual",
"disease",
")",
",",
"involved",
"field",
"fractionated",
"radiation",
"therapy",
"(",
"RT",
")"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
3,
0,
0,
0,
3,
3,
3,
0,
0,
0,
0,
0,
1,
1,
1,
0,
0
] |
NCT01794793 | ,,,,183:192:treatment,,233:249:treatment,,286:301:treatment | Women of child-bearing potential, defined as all women physiologically capable of becoming pregnant, unless they are using highly effective methods of contraception during the study treatment and for 30 days after the final dose of pasireotide s.c. and 84 days after the final dose of pasireotide LAR | 3 | [
"Women",
"of",
"child-bearing",
"potential",
",",
"defined",
"as",
"all",
"women",
"physiologically",
"capable",
"of",
"becoming",
"pregnant",
",",
"unless",
"they",
"are",
"using",
"highly",
"effective",
"methods",
"of",
"contraception",
"during",
"the",
"study",
"treatment",
"and",
"for",
"30",
"days",
"after",
"the",
"final",
"dose",
"of",
"pasireotide",
"s.c.",
"and",
"84",
"days",
"after",
"the",
"final",
"dose",
"of",
"pasireotide",
"LAR"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01793519 | 38:49:chronic_disease,87:96:treatment,101:120:chronic_disease,136:167:treatment | Absence of documentation of negative hepatitis B serologies, absence of completion of treatment for chronic hepatitis B, or absence of suppressive antiviral treatment | 3 | [
"Absence",
"of",
"documentation",
"of",
"negative",
"hepatitis",
"B",
"serologies",
",",
"absence",
"of",
"completion",
"of",
"treatment",
"for",
"chronic",
"hepatitis",
"B",
",",
"or",
"absence",
"of",
"suppressive",
"antiviral",
"treatment"
] | [
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
1,
0,
2,
2,
2,
0,
0,
0,
0,
1,
1,
1
] |
NCT01793519 | 1:10:treatment,14:30:cancer,34:58:cancer, | Treatment of solid malignancy or non-melanoma skin cancer within the past 5 years | 3 | [
"Treatment",
"of",
"solid",
"malignancy",
"or",
"non-melanoma",
"skin",
"cancer",
"within",
"the",
"past",
"5",
"years"
] | [
1,
0,
3,
3,
0,
3,
3,
3,
0,
0,
0,
0,
0
] |
NCT01791543 | 1:36:chronic_disease,50:72:chronic_disease,,148:190:chronic_disease,, | Monomorphic ventricular tachycardia or incessant ventricular arrhythmia (defined as >20% of beats due to ventricular arrhythmia including unifocal premature ventricular contractions (PVCs ), couplets, nonsustained VT) that is causing a decline in LV ejection fraction to less than 40% | 3 | [
"Monomorphic",
"ventricular",
"tachycardia",
"or",
"incessant",
"ventricular",
"arrhythmia",
"(",
"defined",
"as",
">",
"20",
"%",
"of",
"beats",
"due",
"to",
"ventricular",
"arrhythmia",
"including",
"unifocal",
"premature",
"ventricular",
"contractions",
"(",
"PVCs",
")",
",",
"couplets",
",",
"nonsustained",
"VT",
")",
"that",
"is",
"causing",
"a",
"decline",
"in",
"LV",
"ejection",
"fraction",
"to",
"less",
"than",
"40",
"%"
] | [
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01787487 | 9:11:chronic_disease,16:25:chronic_disease,62:75:treatment,84:95:treatment,97:107:treatment,109:123:treatment,125:133:treatment,135:146:treatment,156:173:treatment,177:184:treatment, | For the MF and MDS/MPN-U arms (arms 1 & 2), use of any other standard drug (except hydroxyurea, anagrelide, growth factors, Revlimid, clofarabine, etc) or experimental drug or therapy within 14 days of starting study therapy | 3 | [
"For",
"the",
"MF",
"and",
"MDS/MPN-U",
"arms",
"(",
"arms",
"1",
"&",
"2",
")",
",",
"use",
"of",
"any",
"other",
"standard",
"drug",
"(",
"except",
"hydroxyurea",
",",
"anagrelide",
",",
"growth",
"factors",
",",
"Revlimid",
",",
"clofarabine",
",",
"etc",
")",
"or",
"experimental",
"drug",
"or",
"therapy",
"within",
"14",
"days",
"of",
"starting",
"study",
"therapy"
] | [
0,
0,
2,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
1,
0,
1,
0,
1,
1,
0,
1,
0,
1,
0,
0,
0,
0,
1,
1,
0,
1,
0,
0,
0,
0,
0,
0,
0
] |
NCT01787487 | 15:27:cancer,59:74:cancer,88:97:treatment | patients with malignancies with indolent behavior such as prostate cancer treated with radiation | 3 | [
"patients",
"with",
"malignancies",
"with",
"indolent",
"behavior",
"such",
"as",
"prostate",
"cancer",
"treated",
"with",
"radiation"
] | [
0,
0,
3,
0,
0,
0,
0,
0,
3,
3,
0,
0,
1
] |
NCT01783535 | 28:54:cancer,95:120:cancer,146:159:treatment,171:183:treatment,308:319:treatment | Newly diagnosed, untreated intraocular retinoblastoma. Participants previously diagnosed with unilateral retinoblastoma treated surgically, with focal therapy or needing chemotherapy who develop asynchronous involvement of the contralateral eye, or patients with unilateral retinoblastoma treated only with enucleation or focal therapy who develop asynchronous involvement of the contralateral eye, will be eligible for study | 3 | [
"Newly",
"diagnosed",
",",
"untreated",
"intraocular",
"retinoblastoma",
".",
"Participants",
"previously",
"diagnosed",
"with",
"unilateral",
"retinoblastoma",
"treated",
"surgically",
",",
"with",
"focal",
"therapy",
"or",
"needing",
"chemotherapy",
"who",
"develop",
"asynchronous",
"involvement",
"of",
"the",
"contralateral",
"eye",
",",
"or",
"patients",
"with",
"unilateral",
"retinoblastoma",
"treated",
"only",
"with",
"enucleation",
"or",
"focal",
"therapy",
"who",
"develop",
"asynchronous",
"involvement",
"of",
"the",
"contralateral",
"eye",
",",
"will",
"be",
"eligible",
"for",
"study"
] | [
0,
0,
0,
0,
3,
3,
0,
0,
0,
0,
0,
3,
3,
0,
0,
0,
0,
1,
1,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01777035 | 1:23:chronic_disease,25:48:chronic_disease,50:66:chronic_disease | Traumatic brain injury, multiple limb fractures, pelvic fractures | 3 | [
"Traumatic",
"brain",
"injury",
",",
"multiple",
"limb",
"fractures",
",",
"pelvic",
"fractures"
] | [
2,
2,
2,
0,
2,
2,
2,
0,
2,
2
] |
NCT01774019 | 8:27:chronic_disease,44:61:cancer,63:92:cancer,102:126:cancer | Distal biliary obstruction consistent with pancreatic cancer, distal CBD cholangiocarcinoma or other periampullary malignancy | 3 | [
"Distal",
"biliary",
"obstruction",
"consistent",
"with",
"pancreatic",
"cancer",
",",
"distal",
"CBD",
"cholangiocarcinoma",
"or",
"other",
"periampullary",
"malignancy"
] | [
0,
2,
2,
0,
0,
3,
3,
0,
3,
3,
3,
0,
0,
3,
3
] |
NCT01773694 | 10:28:treatment,32:57:treatment,63:87:treatment | standard excisional surgery or Mohs micrographic surgery with immediate reconstruction | 3 | [
"standard",
"excisional",
"surgery",
"or",
"Mohs",
"micrographic",
"surgery",
"with",
"immediate",
"reconstruction"
] | [
0,
1,
1,
0,
1,
1,
1,
0,
1,
1
] |
NCT01766297 | 1:28:cancer,37:44:cancer,48:56:cancer | Non-epithelial malignancies such as sarcoma or lymphoma | 3 | [
"Non-epithelial",
"malignancies",
"such",
"as",
"sarcoma",
"or",
"lymphoma"
] | [
3,
3,
0,
0,
3,
0,
3
] |
NCT01760655 | 19:29:cancer,33:42:chronic_disease,122:126:treatment | Any hematological malignancy or dyscrasia not cited above which is thought to be high-risk with increased chance of post HSCT relapse | 3 | [
"Any",
"hematological",
"malignancy",
"or",
"dyscrasia",
"not",
"cited",
"above",
"which",
"is",
"thought",
"to",
"be",
"high-risk",
"with",
"increased",
"chance",
"of",
"post",
"HSCT",
"relapse"
] | [
0,
0,
3,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0
] |
NCT01760655 | 1:21:cancer,33:50:chronic_disease,33:55:chronic_disease,80:104:chronic_disease,109:130:chronic_disease | Myelodysplasia (MDS) other than refractory anemia (RA), refractory anemia with rare sideroblasts (RARS), or isolated 5q- syndrome subtypes | 3 | [
"Myelodysplasia",
"(",
"MDS",
")",
"other",
"than",
"refractory",
"anemia",
"(",
"RA",
")",
",",
"refractory",
"anemia",
"with",
"rare",
"sideroblasts",
"(",
"RARS",
")",
",",
"or",
"isolated",
"5q-",
"syndrome",
"subtypes"
] | [
3,
3,
0,
0,
0,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
2,
2,
2,
0,
0,
0,
0,
2,
2,
2,
0
] |
NCT01760005 | 12:18:cancer,,51:71:cancer,73:100:cancer,102:117:cancer,121:138:cancer, | History of cancer within the last 5 years, except basal cell carcinoma, non-squamous skin carcinoma, prostate cancer or carcinoma in situ with no significant progression over the past 2 years | 3 | [
"History",
"of",
"cancer",
"within",
"the",
"last",
"5",
"years",
",",
"except",
"basal",
"cell",
"carcinoma",
",",
"non-squamous",
"skin",
"carcinoma",
",",
"prostate",
"cancer",
"or",
"carcinoma",
"in",
"situ",
"with",
"no",
"significant",
"progression",
"over",
"the",
"past",
"2",
"years"
] | [
0,
0,
3,
0,
0,
0,
0,
0,
0,
0,
3,
3,
3,
3,
3,
3,
3,
0,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01758042 | 26:29:chronic_disease,31:34:chronic_disease,39:44:chronic_disease | Serologic positivity for HIV, HCV, or HbsAg positivity | 3 | [
"Serologic",
"positivity",
"for",
"HIV",
",",
"HCV",
",",
"or",
"HbsAg",
"positivity"
] | [
0,
0,
0,
2,
0,
2,
0,
0,
2,
0
] |
NCT01756040 | 13:27:chronic_disease,34:54:chronic_disease,56:76:chronic_disease,,,104:128:chronic_disease | Significant GI dysfunction (e.g. heme-positive stools, abdominal distension (girth >2 cm baseline), or bilious emesis/aspirates | 3 | [
"Significant",
"GI",
"dysfunction",
"(",
"e.g",
".",
"heme-positive",
"stools",
",",
"abdominal",
"distension",
"(",
"girth",
">",
"2",
"cm",
"baseline",
")",
",",
"or",
"bilious",
"emesis/aspirates"
] | [
0,
2,
2,
0,
0,
0,
2,
2,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2
] |
NCT01754857 | 1:26:cancer,54:69:treatment,71:83:treatment,88:95:treatment | localized prostate cancer (treated definitively with hormone therapy, radiotherapy, or surgery) | 3 | [
"localized",
"prostate",
"cancer",
"(",
"treated",
"definitively",
"with",
"hormone",
"therapy",
",",
"radiotherapy",
",",
"or",
"surgery",
")"
] | [
3,
3,
3,
0,
0,
0,
0,
1,
1,
0,
1,
0,
0,
1,
0
] |
NCT01750567 | 1:34:chronic_disease,77:93:chronic_disease,98:104:chronic_disease,106:142:chronic_disease,144:168:chronic_disease,170:188:chronic_disease,193:219:chronic_disease | Uncontrolled intercurrent illness including, but not limited to, ongoing or active infection and sepsis, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social | 3 | [
"Uncontrolled",
"intercurrent",
"illness",
"including",
",",
"but",
"not",
"limited",
"to",
",",
"ongoing",
"or",
"active",
"infection",
"and",
"sepsis",
",",
"symptomatic",
"congestive",
"heart",
"failure",
",",
"unstable",
"angina",
"pectoris",
",",
"cardiac",
"arrhythmia",
",",
"or",
"psychiatric",
"illness/social"
] | [
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
2,
0,
2,
2,
2,
2,
0,
2,
2,
2,
0,
2,
2,
0,
0,
2,
2
] |
NCT01742338 | 30:34:chronic_disease,36:45:chronic_disease,50:68:chronic_disease | Patients with a diagnosis of COPD, emphysema, or chronic bronchitis | 3 | [
"Patients",
"with",
"a",
"diagnosis",
"of",
"COPD",
",",
"emphysema",
",",
"or",
"chronic",
"bronchitis"
] | [
0,
0,
0,
0,
0,
2,
0,
2,
0,
0,
2,
2
] |
NCT01738009 | 14:31:chronic_disease,60:72:chronic_disease,77:95:chronic_disease | Any unstable cardiac condition (other than well controlled hypertension) or pulmonary problems | 3 | [
"Any",
"unstable",
"cardiac",
"condition",
"(",
"other",
"than",
"well",
"controlled",
"hypertension",
")",
"or",
"pulmonary",
"problems"
] | [
0,
0,
2,
2,
0,
0,
0,
0,
0,
2,
0,
0,
2,
2
] |
NCT01737502 | 37:52:treatment,54:62:treatment,64:75:treatment,77:119:treatment | Unable to discontinue use of potent cytochrome P450, family 3, subfamily A, polypeptide 4 (CYP3A4) inhibitors/inducers | 3 | [
"Unable",
"to",
"discontinue",
"use",
"of",
"potent",
"cytochrome",
"P450",
",",
"family",
"3",
",",
"subfamily",
"A",
",",
"polypeptide",
"4",
"(",
"CYP3A4",
")",
"inhibitors/inducers"
] | [
0,
0,
0,
0,
0,
0,
1,
1,
0,
1,
1,
0,
1,
1,
0,
1,
1,
1,
1,
0,
0
] |
NCT01734512 | 23:32:treatment,34:46:treatment,54:66:treatment | Patients may have had treatment (chemotherapy and/or radiotherapy) for any number of relapses prior to this recurrence | 3 | [
"Patients",
"may",
"have",
"had",
"treatment",
"(",
"chemotherapy",
"and/or",
"radiotherapy",
")",
"for",
"any",
"number",
"of",
"relapses",
"prior",
"to",
"this",
"recurrence"
] | [
0,
0,
0,
0,
1,
0,
1,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01730937 | 8:13:cancer,33:40:cancer,42:50:cancer,52:63:cancer,67:78:cancer | Direct tumor extension into the stomach, duodenum, small bowel or large bowel | 3 | [
"Direct",
"tumor",
"extension",
"into",
"the",
"stomach",
",",
"duodenum",
",",
"small",
"bowel",
"or",
"large",
"bowel"
] | [
0,
3,
0,
0,
0,
3,
0,
3,
0,
3,
3,
0,
3,
3
] |
NCT01730937 | 16:26:cancer,35:63:cancer,68:91:cancer, | Prior invasive malignancy (except non-melanomatous skin cancer and T1 renal cell carcinoma) unless disease free for a minimum of 2 years | 3 | [
"Prior",
"invasive",
"malignancy",
"(",
"except",
"non-melanomatous",
"skin",
"cancer",
"and",
"T1",
"renal",
"cell",
"carcinoma",
")",
"unless",
"disease",
"free",
"for",
"a",
"minimum",
"of",
"2",
"years"
] | [
0,
0,
3,
0,
0,
3,
3,
3,
0,
3,
3,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01730794 | 15:31:treatment,33:40:treatment,45:57:treatment | Patients with major esophageal, gastric and oral surgery | 3 | [
"Patients",
"with",
"major",
"esophageal",
",",
"gastric",
"and",
"oral",
"surgery"
] | [
0,
0,
1,
1,
0,
1,
0,
1,
1
] |
NCT01730118 | 12:23:treatment,,,59:80:cancer,85:95:cancer,120:130:treatment, | Cumulative doxorubicin dose >= 400mg/m^2 (>450 mg/m^2 for malignant soft tissue and bone tumor patients) or cumulative epirubicin dose >= 800mg/m^2 | 3 | [
"Cumulative",
"doxorubicin",
"dose",
">",
"=",
"400mg/m^2",
"(",
">",
"450",
"mg/m^2",
"for",
"malignant",
"soft",
"tissue",
"and",
"bone",
"tumor",
"patients",
")",
"or",
"cumulative",
"epirubicin",
"dose",
">",
"=",
"800mg/m^2"
] | [
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
3,
3,
0,
3,
3,
0,
0,
0,
0,
1,
0,
0,
0,
0
] |
NCT01730118 | 22:36:cancer,40:54:cancer,70:75:cancer,104:120:cancer,160:176:chronic_disease,180:187:treatment,191:200:treatment,261:272:chronic_disease, | Patients with active CNS metastases or leptomeningeal involvement by tumor (patients with a history of brain metastases who have been successfully treated for brain metastasis by surgery or radiation and who have not had any evidence of the new or progressive CNS disease fot more than 12 months are eligible) | 3 | [
"Patients",
"with",
"active",
"CNS",
"metastases",
"or",
"leptomeningeal",
"involvement",
"by",
"tumor",
"(",
"patients",
"with",
"a",
"history",
"of",
"brain",
"metastases",
"who",
"have",
"been",
"successfully",
"treated",
"for",
"brain",
"metastasis",
"by",
"surgery",
"or",
"radiation",
"and",
"who",
"have",
"not",
"had",
"any",
"evidence",
"of",
"the",
"new",
"or",
"progressive",
"CNS",
"disease",
"fot",
"more",
"than",
"12",
"months",
"are",
"eligible",
")"
] | [
0,
0,
0,
2,
2,
0,
3,
0,
0,
3,
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01730118 | 14:33:chronic_disease,52:61:treatment,121:135:cancer | Recurrent or progressive disease on prior standard therapies with known clinical benefit with the exception of adjuvant bladder cancer population | 3 | [
"Recurrent",
"or",
"progressive",
"disease",
"on",
"prior",
"standard",
"therapies",
"with",
"known",
"clinical",
"benefit",
"with",
"the",
"exception",
"of",
"adjuvant",
"bladder",
"cancer",
"population"
] | [
0,
0,
2,
2,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
3,
0
] |
NCT01730118 | 32:43:cancer,74:84:cancer,85:97:cancer,121:139:treatment,172:189:treatment | with malignant soft tissue and bone tumors and recurrent or progressive, metastatic solid tumors who have progressed on standard therapies with known benefit but for whom anti-HER2 therapy is not clinically indicated | 3 | [
"with",
"malignant",
"soft",
"tissue",
"and",
"bone",
"tumors",
"and",
"recurrent",
"or",
"progressive",
",",
"metastatic",
"solid",
"tumors",
"who",
"have",
"progressed",
"on",
"standard",
"therapies",
"with",
"known",
"benefit",
"but",
"for",
"whom",
"anti-HER2",
"therapy",
"is",
"not",
"clinically",
"indicated"
] | [
0,
0,
0,
0,
0,
3,
3,
0,
0,
0,
0,
0,
3,
3,
3,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0
] |
NCT01720836 | 7:18:chronic_disease,22:38:treatment,45:55:treatment | Known Hepatitis B on immunomodulators (i.e. interferon) | 3 | [
"Known",
"Hepatitis",
"B",
"on",
"immunomodulators",
"(",
"i.e",
".",
"interferon",
")"
] | [
0,
2,
2,
0,
1,
0,
0,
0,
1,
0
] |
NCT01716806 | 1:13:treatment,15:27:treatment,29:38:treatment,68:81:treatment,,127:137:treatment | Chemotherapy, radiotherapy, biologics, and/or other treatment with immunotherapy not completed 4 weeks prior to first dose of study drug | 3 | [
"Chemotherapy",
",",
"radiotherapy",
",",
"biologics",
",",
"and/or",
"other",
"treatment",
"with",
"immunotherapy",
"not",
"completed",
"4",
"weeks",
"prior",
"to",
"first",
"dose",
"of",
"study",
"drug"
] | [
1,
0,
1,
0,
1,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT01714596 | 31:87:treatment,94:100:treatment,102:108:treatment,110:116:treatment | Patients who are currently on Selective Serotonin Reuptake Inhibitor (SSRI) medication (e.g. Zoloft, Prozac, Celexa), and bacteria is MRSA | 3 | [
"Patients",
"who",
"are",
"currently",
"on",
"Selective",
"Serotonin",
"Reuptake",
"Inhibitor",
"(",
"SSRI",
")",
"medication",
"(",
"e.g",
".",
"Zoloft",
",",
"Prozac",
",",
"Celexa",
")",
",",
"and",
"bacteria",
"is",
"MRSA"
] | [
0,
0,
0,
0,
0,
1,
1,
1,
1,
1,
1,
0,
0,
0,
0,
0,
1,
0,
1,
0,
1,
0,
0,
0,
0,
0,
0
] |
NCT01707394 | 23:38:treatment,60:95:treatment,97:123:treatment,127:151:treatment | Inability to tolerate oral medication or administration of oral medication via an enteral tube (nasogastric tube [NG tube] or gastronomy tube [G-tube]) | 3 | [
"Inability",
"to",
"tolerate",
"oral",
"medication",
"or",
"administration",
"of",
"oral",
"medication",
"via",
"an",
"enteral",
"tube",
"(",
"nasogastric",
"tube",
"[",
"NG",
"tube",
"]",
"or",
"gastronomy",
"tube",
"[",
"G-tube",
"]",
")"
] | [
0,
0,
0,
1,
1,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
1,
1,
1,
1,
0,
0,
0,
1,
1,
1,
0,
0,
0
] |
NCT01703117 | 34:54:chronic_disease,84:105:chronic_disease,141:164:treatment,166:181:chronic_disease,202:226:chronic_disease, | Any unstable serious co-existing medical condition(s) including but not limited to myocardial infarction, coronary artery disease requiring coronary bypass surgery, unstable angina, clinically evident congestive heart failure within 6 months prior to the screening visit | 3 | [
"Any",
"unstable",
"serious",
"co-existing",
"medical",
"condition",
"(",
"s",
")",
"including",
"but",
"not",
"limited",
"to",
"myocardial",
"infarction",
",",
"coronary",
"artery",
"disease",
"requiring",
"coronary",
"bypass",
"surgery",
",",
"unstable",
"angina",
",",
"clinically",
"evident",
"congestive",
"heart",
"failure",
"within",
"6",
"months",
"prior",
"to",
"the",
"screening",
"visit"
] | [
0,
2,
2,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01703117 | 1:4:allergy_name,30:44:chronic_disease,46:60:allergy_name,62:68:allergy_name,70:79:allergy_name,81:95:allergy_name,97:109:allergy_name | MRI contraindication (severe claustrophobia, metal implants, shunts, pacemaker, joint implants, metal valves) | 3 | [
"MRI",
"contraindication",
"(",
"severe",
"claustrophobia",
",",
"metal",
"implants",
",",
"shunts",
",",
"pacemaker",
",",
"joint",
"implants",
",",
"metal",
"valves",
")"
] | [
4,
0,
0,
0,
2,
0,
4,
4,
0,
4,
0,
4,
0,
4,
4,
0,
0,
0,
0
] |
NCT01701986 | 20:29:chronic_disease,,,43:57:chronic_disease,75:94:chronic_disease,98:118:chronic_disease | Evidence of either cirrhosis or stage 3-4 liver fibrosis in patients with chronic hepatitis C or positive hepatitis C serology | 3 | [
"Evidence",
"of",
"either",
"cirrhosis",
"or",
"stage",
"3-4",
"liver",
"fibrosis",
"in",
"patients",
"with",
"chronic",
"hepatitis",
"C",
"or",
"positive",
"hepatitis",
"C",
"serology"
] | [
0,
0,
0,
2,
0,
0,
0,
2,
2,
0,
0,
0,
2,
2,
2,
0,
2,
2,
2,
0
] |
NCT01697865 | 1:25:chronic_disease,33:65:chronic_disease,82:104:chronic_disease | Shoulder pseudoparalysis due to chronic rotator cuff dysfunction with or without glenohumeral arthritis | 3 | [
"Shoulder",
"pseudoparalysis",
"due",
"to",
"chronic",
"rotator",
"cuff",
"dysfunction",
"with",
"or",
"without",
"glenohumeral",
"arthritis"
] | [
2,
2,
0,
0,
2,
2,
2,
2,
0,
0,
0,
2,
2
] |
NCT01697371 | 7:26:cancer,38:47:cancer,64:92:cancer, | Prior invasive malignancy other than liver met primary (except non-melanomatous skin cancer) unless disease free for > 3years | 3 | [
"Prior",
"invasive",
"malignancy",
"other",
"than",
"liver",
"met",
"primary",
"(",
"except",
"non-melanomatous",
"skin",
"cancer",
")",
"unless",
"disease",
"free",
"for",
">",
"3years"
] | [
0,
3,
3,
0,
0,
3,
3,
0,
0,
0,
3,
3,
3,
0,
0,
0,
0,
0,
0,
0
] |
NCT01697293 | 23:32:treatment,36:88:treatment,107:116:treatment,120:133:cancer | Patients who received tamoxifen or another selective estrogen receptor modulator (SERM) for prevention or treatment of breast cancer or for other indications | 3 | [
"Patients",
"who",
"received",
"tamoxifen",
"or",
"another",
"selective",
"estrogen",
"receptor",
"modulator",
"(",
"SERM",
")",
"for",
"prevention",
"or",
"treatment",
"of",
"breast",
"cancer",
"or",
"for",
"other",
"indications"
] | [
0,
0,
0,
1,
0,
1,
1,
1,
1,
1,
1,
0,
0,
0,
0,
0,
1,
0,
3,
3,
0,
0,
0,
0
] |
NCT01697293 | 1:13:chronic_disease,21:52:cancer,70:90:treatment,109:118:treatment,122:135:cancer | osteoporosis, prior ductal carcinoma in situ [DCIS]), or who receive aromatase inhibitors for prevention or treatment of breast cancer, are eligible | 3 | [
"osteoporosis",
",",
"prior",
"ductal",
"carcinoma",
"in",
"situ",
"[",
"DCIS",
"]",
")",
",",
"or",
"who",
"receive",
"aromatase",
"inhibitors",
"for",
"prevention",
"or",
"treatment",
"of",
"breast",
"cancer",
",",
"are",
"eligible"
] | [
2,
0,
0,
3,
3,
3,
3,
3,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
1,
0,
3,
3,
0,
0,
0
] |
NCT01697293 | 5:10:cancer,84:99:treatment,101:148:treatment | the tumor must be human epidermal growth factor receptor 2 (Her2)/neu negative (by DAKO HercepTest, fluorescence based in situ hybridization [FISH], or other approved assay) | 3 | [
"the",
"tumor",
"must",
"be",
"human",
"epidermal",
"growth",
"factor",
"receptor",
"2",
"(",
"Her2",
")",
"/neu",
"negative",
"(",
"by",
"DAKO",
"HercepTest",
",",
"fluorescence",
"based",
"in",
"situ",
"hybridization",
"[",
"FISH",
"]",
",",
"or",
"other",
"approved",
"assay",
")"
] | [
0,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
1,
1,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01695980 | 11:29:treatment,34:57:chronic_disease,61:80:chronic_disease,,, | requiring adenotonsillectomy for Obstructive sleep apnea or chronic tonsillitis between the ages of 2-16 | 3 | [
"requiring",
"adenotonsillectomy",
"for",
"Obstructive",
"sleep",
"apnea",
"or",
"chronic",
"tonsillitis",
"between",
"the",
"ages",
"of",
"2-16"
] | [
0,
1,
0,
2,
2,
2,
0,
2,
2,
0,
0,
0,
0,
0
] |
NCT01688388 | 1:6:cancer,24:29:cancer,33:58:cancer,106:124:cancer, | Tumor. Single discrete tumor or focal microcalcifications that can be imaged on a specimen radiograph or multifocal disease within the same quadrant with a maximum dimension of equal to or less than 2.5 cm | 3 | [
"Tumor",
".",
"Single",
"discrete",
"tumor",
"or",
"focal",
"microcalcifications",
"that",
"can",
"be",
"imaged",
"on",
"a",
"specimen",
"radiograph",
"or",
"multifocal",
"disease",
"within",
"the",
"same",
"quadrant",
"with",
"a",
"maximum",
"dimension",
"of",
"equal",
"to",
"or",
"less",
"than",
"2.5",
"cm"
] | [
3,
0,
0,
0,
3,
0,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01684397 | 1:7:treatment,25:64:cancer,70:80:cancer | Biopsy/pathology-proven clear cell renal cell carcinoma (CCRCC) with metastases | 3 | [
"Biopsy/pathology-proven",
"clear",
"cell",
"renal",
"cell",
"carcinoma",
"(",
"CCRCC",
")",
"with",
"metastases"
] | [
1,
3,
3,
3,
3,
3,
3,
0,
0,
0,
3
] |
NCT01683825 | 1:7:treatment,15:26:chronic_disease,125:139:treatment | Biopsy proven amyloidosis outside the heart with typical echocardiographic appearance of cardiac involvement, or a positive cardiac biopsy | 3 | [
"Biopsy",
"proven",
"amyloidosis",
"outside",
"the",
"heart",
"with",
"typical",
"echocardiographic",
"appearance",
"of",
"cardiac",
"involvement",
",",
"or",
"a",
"positive",
"cardiac",
"biopsy"
] | [
1,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0
] |
NCT01681264 | 53:69:allergy_name,76:83:allergy_name,85:95:allergy_name,97:104:allergy_name,106:134:allergy_name | Allergic to or has had a severe adverse reaction to study medication (i.e. opioids, guanfacine, lactose, vitamin B2 a.k.a. riboflavin) | 3 | [
"Allergic",
"to",
"or",
"has",
"had",
"a",
"severe",
"adverse",
"reaction",
"to",
"study",
"medication",
"(",
"i.e",
".",
"opioids",
",",
"guanfacine",
",",
"lactose",
",",
"vitamin",
"B2",
"a.k.a",
".",
"riboflavin",
")"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
4,
4,
0,
0,
0,
4,
0,
4,
0,
4,
0,
4,
4,
4,
4,
0,
0
] |
NCT01681264 | 43:55:chronic_disease,59:79:chronic_disease,155:158:treatment | Has other chronic pain conditions such as fibromyalgia or joint osteoarthritis that are predominant over back and neck pain with regard to its intensity (VAS) | 3 | [
"Has",
"other",
"chronic",
"pain",
"conditions",
"such",
"as",
"fibromyalgia",
"or",
"joint",
"osteoarthritis",
"that",
"are",
"predominant",
"over",
"back",
"and",
"neck",
"pain",
"with",
"regard",
"to",
"its",
"intensity",
"(",
"VAS",
")"
] | [
0,
0,
0,
0,
0,
0,
0,
2,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0
] |
NCT01681264 | 44:52:treatment,61:69:treatment,71:93:chronic_disease | subjects will be warned of side effects of morphine such as sedation, respiratory depression at the enrollment | 3 | [
"subjects",
"will",
"be",
"warned",
"of",
"side",
"effects",
"of",
"morphine",
"such",
"as",
"sedation",
",",
"respiratory",
"depression",
"at",
"the",
"enrollment"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
1,
0,
2,
2,
0,
0,
0
] |
NCT01676753 | 34:52:chronic_disease,71:89:treatment,,125:149:treatment,151:166:treatment,170:193:treatment,202:221:treatment,229:238:treatment,240:247:treatment,252:298:treatment,303:337:chronic_disease | Patient is diagnosed with active autoimmune disease that has required systemic treatment in past 2 years (i.e., with use of disease modifying agents, corticosteroids or immunosuppressive drugs). Note: replacement therapy (e.g., thyroxine, insulin, or physiologic corticosteroid replacement therapy for adrenal or pituitary insufficiency) is not considered a form of systemic treatment | 3 | [
"Patient",
"is",
"diagnosed",
"with",
"active",
"autoimmune",
"disease",
"that",
"has",
"required",
"systemic",
"treatment",
"in",
"past",
"2",
"years",
"(",
"i.e.",
",",
"with",
"use",
"of",
"disease",
"modifying",
"agents",
",",
"corticosteroids",
"or",
"immunosuppressive",
"drugs",
")",
".",
"Note",
":",
"replacement",
"therapy",
"(",
"e.g.",
",",
"thyroxine",
",",
"insulin",
",",
"or",
"physiologic",
"corticosteroid",
"replacement",
"therapy",
"for",
"adrenal",
"or",
"pituitary",
"insufficiency",
")",
"is",
"not",
"considered",
"a",
"form",
"of",
"systemic",
"treatment"
] | [
0,
0,
0,
0,
0,
2,
1,
1,
1,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
1,
1,
0,
0,
0,
0,
1,
1,
0,
0,
0,
1,
0,
1,
0,
0,
1,
1,
1,
1,
0,
2,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01676259 | 22:33:treatment,36:50:treatment,65:74:treatment | Allocated to receive Gemcitabine + nab-Paclitaxel as first line treatment | 3 | [
"Allocated",
"to",
"receive",
"Gemcitabine",
"+",
"nab-Paclitaxel",
"as",
"first",
"line",
"treatment"
] | [
0,
0,
0,
1,
0,
1,
0,
0,
0,
1
] |
NCT01675154 | 1:37:treatment,9:16:treatment,22:37:treatment,39:46:treatment | Current therapy with anti-coagulants, digoxin and anti-arrhythmics | 3 | [
"Current",
"therapy",
"with",
"anti-coagulants",
",",
"digoxin",
"and",
"anti-arrhythmics"
] | [
1,
1,
1,
1,
0,
1,
0,
0
] |
NCT01670877 | 21:37:cancer,75:84:treatment,96:104:treatment, | Patients with known brain metastasis are eligible, but must have received radiation and be off steroids and stable (without evidence of disease progression by imaging or exam) for 3 months | 3 | [
"Patients",
"with",
"known",
"brain",
"metastasis",
"are",
"eligible",
",",
"but",
"must",
"have",
"received",
"radiation",
"and",
"be",
"off",
"steroids",
"and",
"stable",
"(",
"without",
"evidence",
"of",
"disease",
"progression",
"by",
"imaging",
"or",
"exam",
")",
"for",
"3",
"months"
] | [
0,
0,
0,
3,
3,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01668602 | 22:61:treatment,78:86:chronic_disease,88:102:treatment,165:173:chronic_disease,,222:241:chronic_disease,256:274:chronic_disease,298:305:chronic_disease, | Contraindications to transcranial magnetic stimulation (TMS) are: history of seizures, metal implants in the head or face, history of recurring or severe headaches/migraine, headache within the past 24 hours, presence of skull abnormalities or fractures, hemorrhagic stroke, history of dizziness, syncope, nausea, or loss of consciousness in the past 12 months | 3 | [
"Contraindications",
"to",
"transcranial",
"magnetic",
"stimulation",
"(",
"TMS",
")",
"are",
":",
"history",
"of",
"seizures",
",",
"metal",
"implants",
"in",
"the",
"head",
"or",
"face",
",",
"history",
"of",
"recurring",
"or",
"severe",
"headaches/migraine",
",",
"headache",
"within",
"the",
"past",
"24",
"hours",
",",
"presence",
"of",
"skull",
"abnormalities",
"or",
"fractures",
",",
"hemorrhagic",
"stroke",
",",
"history",
"of",
"dizziness",
",",
"syncope",
",",
"nausea",
",",
"or",
"loss",
"of",
"consciousness",
"in",
"the",
"past",
"12",
"months"
] | [
0,
0,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
2,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01666665 | 18:22:chronic_disease,24:27:chronic_disease,29:32:chronic_disease | Known history of AIDS, ARC, HIV | 3 | [
"Known",
"history",
"of",
"AIDS",
",",
"ARC",
",",
"HIV"
] | [
0,
0,
0,
2,
0,
2,
0,
2
] |
NCT01659541 | 11:15:chronic_disease,17:31:chronic_disease,35:48:chronic_disease | Untreated lung, cardiovascular or brain disease | 3 | [
"Untreated",
"lung",
",",
"cardiovascular",
"or",
"brain",
"disease"
] | [
0,
2,
0,
2,
0,
2,
2
] |
NCT01653080 | 1:14:chronic_disease,26:41:chronic_disease,43:59:treatment,61:72:cancer | Renal disease (including solitary kidney, renal transplant, renal tumor) | 3 | [
"Renal",
"disease",
"(",
"including",
"solitary",
"kidney",
",",
"renal",
"transplant",
",",
"renal",
"tumor",
")"
] | [
2,
2,
0,
0,
2,
2,
0,
3,
3,
0,
0,
0,
0
] |
NCT01648751 | 39:62:chronic_disease,71:86:treatment,88:111:chronic_disease,124:130:chronic_disease | Contraindication to hormone use (i.e. thromboembolic disorder, use of anti-coagulants, coronary artery disease, history of stroke) | 3 | [
"Contraindication",
"to",
"hormone",
"use",
"(",
"i.e",
".",
"thromboembolic",
"disorder",
",",
"use",
"of",
"anti-coagulants",
",",
"coronary",
"artery",
"disease",
",",
"history",
"of",
"stroke",
")"
] | [
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
1,
0,
2,
2,
2,
0,
0,
0,
2,
0
] |
NCT01648023 | 6:27:chronic_disease,34:42:chronic_disease,46:51:cancer | Main portal vein occlusion (e.g. thrombus or tumor) | 3 | [
"Main",
"portal",
"vein",
"occlusion",
"(",
"e.g",
".",
"thrombus",
"or",
"tumor",
")"
] | [
0,
2,
2,
2,
0,
0,
0,
2,
0,
3,
0
] |
NCT01648023 | 21:31:cancer,54:80:cancer,85:137:cancer | Presence of another malignancy with the exception of cervical carcinoma in situ and stage I basal or squamous cell carcinoma of the skin | 3 | [
"Presence",
"of",
"another",
"malignancy",
"with",
"the",
"exception",
"of",
"cervical",
"carcinoma",
"in",
"situ",
"and",
"stage",
"I",
"basal",
"or",
"squamous",
"cell",
"carcinoma",
"of",
"the",
"skin"
] | [
0,
0,
0,
3,
0,
0,
0,
0,
3,
3,
3,
3,
0,
3,
3,
3,
3,
3,
3,
3,
3,
3,
3
] |
NCT01639508 | 1:14:treatment,20:31:treatment,33:70:treatment,,137:150:treatment,,207:220:treatment,226:241:treatment,243:259:treatment,,360:373:treatment | Major surgery (eg, thoracotomy, removal or biopsy of brain metastasis) within 3 months before Week 1 Day 1. Complete wound healing from major surgery must have occurred 1 month before Week 1 Day 1 and from minor surgery (eg, simple excision, tooth extraction) at least 10 days before Week 1 Day 1. Subjects with clinically relevant ongoing complications from prior surgery are not eligible | 3 | [
"Major",
"surgery",
"(",
"eg",
",",
"thoracotomy",
",",
"removal",
"or",
"biopsy",
"of",
"brain",
"metastasis",
")",
"within",
"3",
"months",
"before",
"Week",
"1",
"Day",
"1",
".",
"Complete",
"wound",
"healing",
"from",
"major",
"surgery",
"must",
"have",
"occurred",
"1",
"month",
"before",
"Week",
"1",
"Day",
"1",
"and",
"from",
"minor",
"surgery",
"(",
"eg",
",",
"simple",
"excision",
",",
"tooth",
"extraction",
")",
"at",
"least",
"10",
"days",
"before",
"Week",
"1",
"Day",
"1",
".",
"Subjects",
"with",
"clinically",
"relevant",
"ongoing",
"complications",
"from",
"prior",
"surgery",
"are",
"not",
"eligible"
] | [
1,
1,
0,
0,
0,
1,
0,
1,
1,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
1,
1,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0
] |
NCT01639508 | ,,87:102:treatment,110:118:chronic_disease,156:159:chronic_disease | The subject has not recovered to baseline or CTCAE ≤ Grade 1 from toxicity due to all prior therapies except alopecia and other non-clinically significant AEs | 3 | [
"The",
"subject",
"has",
"not",
"recovered",
"to",
"baseline",
"or",
"CTCAE",
"≤",
"Grade",
"1",
"from",
"toxicity",
"due",
"to",
"all",
"prior",
"therapies",
"except",
"alopecia",
"and",
"other",
"non-clinically",
"significant",
"AEs"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
2,
0,
0,
0,
0,
2
] |
NCT01639508 | 1:21:chronic_disease,32:59:treatment,44:59:treatment | thromboembolic event requiring therapeutic anticoagulation except if anticoagulation is as stipulated in Exclusion Criterium #6 | 3 | [
"thromboembolic",
"event",
"requiring",
"therapeutic",
"anticoagulation",
"except",
"if",
"anticoagulation",
"is",
"as",
"stipulated",
"in",
"Exclusion",
"Criterium",
"#",
"6"
] | [
2,
2,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01631617 | 46:55:treatment,57:82:treatment,84:105:treatment,110:137:treatment,,,220:229:treatment | Subjects receiving or planning to receive an IND agent, ultraviolet light therapy, monoclonal antibodies, or systemic immunosuppressants within 7 days or 5 half-lives (whichever is the longer time period) of initiating treatment on this protocol | 3 | [
"Subjects",
"receiving",
"or",
"planning",
"to",
"receive",
"an",
"IND",
"agent",
",",
"ultraviolet",
"light",
"therapy",
",",
"monoclonal",
"antibodies",
",",
"or",
"systemic",
"immunosuppressants",
"within",
"7",
"days",
"or",
"5",
"half-lives",
"(",
"whichever",
"is",
"the",
"longer",
"time",
"period",
")",
"of",
"initiating",
"treatment",
"on",
"this",
"protocol"
] | [
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
1,
1,
1,
0,
1,
1,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0
] |
NCT01627821 | 10:23:chronic_disease,64:79:chronic_disease,81:92:chronic_disease,95:121:chronic_disease,123:142:chronic_disease,144:155:chronic_disease,157:172:chronic_disease,177:195:chronic_disease | Cause of heart failure due to, or associated with, uncorrected thyroid disease, obstructive / restrictive cardiomyopathy, pericardial disease, amyloidosis, dermatomyositis, or active myocarditis | 3 | [
"Cause",
"of",
"heart",
"failure",
"due",
"to",
",",
"or",
"associated",
"with",
",",
"uncorrected",
"thyroid",
"disease",
",",
"obstructive",
"/",
"restrictive",
"cardiomyopathy",
",",
"pericardial",
"disease",
",",
"amyloidosis",
",",
"dermatomyositis",
",",
"or",
"active",
"myocarditis"
] | [
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
2,
0,
2,
2,
0,
2,
2,
0,
2,
0,
2,
0,
0,
2,
2
] |
NCT01626586 | 38:56:chronic_disease,58:90:chronic_disease,109:125:chronic_disease,127:136:chronic_disease,153:164:chronic_disease | They have a co-existing diagnosis of mental retardation, pervasive developmental disorder, substance abuse, eating disorders, psychosis, or other acute psychiatric or medical needs, such as suicidality | 3 | [
"They",
"have",
"a",
"co-existing",
"diagnosis",
"of",
"mental",
"retardation",
",",
"pervasive",
"developmental",
"disorder",
",",
"substance",
"abuse",
",",
"eating",
"disorders",
",",
"psychosis",
",",
"or",
"other",
"acute",
"psychiatric",
"or",
"medical",
"needs",
",",
"such",
"as",
"suicidality"
] | [
0,
0,
0,
0,
0,
0,
2,
2,
0,
2,
2,
2,
0,
0,
0,
0,
2,
2,
0,
2,
0,
0,
0,
0,
2,
0,
0,
0,
0,
0,
0,
0
] |
NCT01626079 | 1:18:treatment,31:48:cancer,50:58:chronic_disease,62:72:chronic_disease | Echocardiographic evidence of intracardiac mass, thrombus or vegetation | 3 | [
"Echocardiographic",
"evidence",
"of",
"intracardiac",
"mass",
",",
"thrombus",
"or",
"vegetation"
] | [
1,
0,
0,
3,
3,
0,
2,
0,
2
] |
NCT01626079 | 16:49:treatment,16:55:treatment,98:132:treatment, | Implant of any Cardiac Resynchronization Therapy (CRT) or Cardiac Resynchronization Therapy with cardioverter-defibrillator (CRT-D) within the last 30days prior to subject registration | 3 | [
"Implant",
"of",
"any",
"Cardiac",
"Resynchronization",
"Therapy",
"(",
"CRT",
")",
"or",
"Cardiac",
"Resynchronization",
"Therapy",
"with",
"cardioverter-defibrillator",
"(",
"CRT-D",
")",
"within",
"the",
"last",
"30days",
"prior",
"to",
"subject",
"registration"
] | [
0,
0,
0,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01626079 | 1:35:treatment,53:86:treatment,95:137:treatment | Prior mitral valve leaflet surgery or any currently implanted prosthetic mitral valve, or any prior transcatheter mitral valve procedure | 3 | [
"Prior",
"mitral",
"valve",
"leaflet",
"surgery",
"or",
"any",
"currently",
"implanted",
"prosthetic",
"mitral",
"valve",
",",
"or",
"any",
"prior",
"transcatheter",
"mitral",
"valve",
"procedure"
] | [
1,
1,
1,
1,
1,
0,
0,
0,
1,
1,
1,
1,
0,
0,
0,
1,
1,
1,
1,
1
] |